OBJECTIVE: To assess the effect on cognition of a controlled intervention testing Mediterranean diets (MedDiet). DESIGN: Randomized trial after 6.5 years of nutritional intervention. SETTING:Eight primary care centers affiliated to the University of Navarra. PARTICIPANTS: A random subsample of 285 participants (95 randomly allocated to each of 3 groups) of the PREDIMED-NAVARRA trial. All of them were at high vascular risk (44.8% men, 74.1±5.7 years at cognitive evaluation). INTERVENTIONS: Nutritional intervention comparing two MedDiets (supplemented with extra-virgin olive oil [EVOO] or mixed nuts) versus a low-fat control diet. Participants received intensive education to increase adherence to the intended intervention. Participants allocated to the MedDiet groups received EVOO (1 l/week) or 30 g/day of mixed nuts. Dietary habits were evaluated using a validated 137-item food frequency questionnaire (FFQ). Additionally, adherence to MedDiet was appraised using a 14-item questionnaire both at baseline and yearly thereafter. MEASUREMENTS: Cognitive performance as a main outcome and cognitive status (normal, mild cognitive impairment [MCI] or dementia) as a secondary outcome were evaluated by two neurologists blinded to group assignment after 6.5 years of nutritional intervention. RESULTS: Better post-trial cognitive performance versus control in all cognitive domains and significantly better performance across fluency and memory tasks were observed for participants allocated to the MedDiet+EVOO group. After adjustment for sex, age, education, apolipoprotein E genotype, family history of cognitive impairment/dementia, smoking, physical activity, body mass index, hypertension, dyslipidaemia, diabetes, alcohol and total energy intake, this group also showed lower MCI (OR=0.34 95% CI: 0.12-0.97) compared with control group. Participants assigned to MedDiet+Nuts group did not differ from controls. CONCLUSION: A long-term intervention with an EVOO-rich MedDiet resulted in a better cognitive function in comparison with a control diet. However, non-significant differences were found for most cognitive domains. Participants allocated to an EVOO-rich MedDiet had less MCI than controls.
RCT Entities:
OBJECTIVE: To assess the effect on cognition of a controlled intervention testing Mediterranean diets (MedDiet). DESIGN: Randomized trial after 6.5 years of nutritional intervention. SETTING: Eight primary care centers affiliated to the University of Navarra. PARTICIPANTS: A random subsample of 285 participants (95 randomly allocated to each of 3 groups) of the PREDIMED-NAVARRA trial. All of them were at high vascular risk (44.8% men, 74.1±5.7 years at cognitive evaluation). INTERVENTIONS: Nutritional intervention comparing two MedDiets (supplemented with extra-virgin olive oil [EVOO] or mixed nuts) versus a low-fat control diet. Participants received intensive education to increase adherence to the intended intervention. Participants allocated to the MedDiet groups received EVOO (1 l/week) or 30 g/day of mixed nuts. Dietary habits were evaluated using a validated 137-item food frequency questionnaire (FFQ). Additionally, adherence to MedDiet was appraised using a 14-item questionnaire both at baseline and yearly thereafter. MEASUREMENTS: Cognitive performance as a main outcome and cognitive status (normal, mild cognitive impairment [MCI] or dementia) as a secondary outcome were evaluated by two neurologists blinded to group assignment after 6.5 years of nutritional intervention. RESULTS: Better post-trial cognitive performance versus control in all cognitive domains and significantly better performance across fluency and memory tasks were observed for participants allocated to the MedDiet+EVOO group. After adjustment for sex, age, education, apolipoprotein E genotype, family history of cognitive impairment/dementia, smoking, physical activity, body mass index, hypertension, dyslipidaemia, diabetes, alcohol and total energy intake, this group also showed lower MCI (OR=0.34 95% CI: 0.12-0.97) compared with control group. Participants assigned to MedDiet+Nuts group did not differ from controls. CONCLUSION: A long-term intervention with an EVOO-rich MedDiet resulted in a better cognitive function in comparison with a control diet. However, non-significant differences were found for most cognitive domains. Participants allocated to an EVOO-rich MedDiet had less MCI than controls.
Authors: Jordi Peña-Casanova; Nina Gramunt-Fombuena; Sonia Quiñones-Ubeda; Gonzalo Sánchez-Benavides; Miquel Aguilar; Dolors Badenes; José Luis Molinuevo; Alfredo Robles; Maria Sagrario Barquero; María Payno; Carmen Antúnez; Carlos Martínez-Parra; Anna Frank-García; Manuel Fernández; Verónica Alfonso; Josep M Sol; Rafael Blesa Journal: Arch Clin Neuropsychol Date: 2009-08-06 Impact factor: 2.813
Authors: Ramon Estruch; Miguel Angel Martínez-González; Dolores Corella; Jordi Salas-Salvadó; Valentina Ruiz-Gutiérrez; María Isabel Covas; Miguel Fiol; Enrique Gómez-Gracia; Mari Carmen López-Sabater; Ernest Vinyoles; Fernando Arós; Manuel Conde; Carlos Lahoz; José Lapetra; Guillermo Sáez; Emilio Ros Journal: Ann Intern Med Date: 2006-07-04 Impact factor: 25.391
Authors: J López-Miranda; F Pérez-Jiménez; E Ros; R De Caterina; L Badimón; M I Covas; E Escrich; J M Ordovás; F Soriguer; R Abiá; C Alarcón de la Lastra; M Battino; D Corella; J Chamorro-Quirós; J Delgado-Lista; D Giugliano; K Esposito; R Estruch; J M Fernandez-Real; J J Gaforio; C La Vecchia; D Lairon; F López-Segura; P Mata; J A Menéndez; F J Muriana; J Osada; D B Panagiotakos; J A Paniagua; P Pérez-Martinez; J Perona; M A Peinado; M Pineda-Priego; H E Poulsen; J L Quiles; M C Ramírez-Tortosa; J Ruano; L Serra-Majem; R Solá; M Solanas; V Solfrizzi; R de la Torre-Fornell; A Trichopoulou; M Uceda; J M Villalba-Montoro; J R Villar-Ortiz; F Visioli; N Yiannakouris Journal: Nutr Metab Cardiovasc Dis Date: 2010-03-19 Impact factor: 4.222
Authors: V Benetou; A Trichopoulou; P Orfanos; A Naska; P Lagiou; P Boffetta; D Trichopoulos Journal: Br J Cancer Date: 2008-07-08 Impact factor: 7.640
Authors: Natalie C Fortune; Emily W Harville; Jack M Guralnik; Jeanette Gustat; Wei Chen; Lu Qi; Lydia A Bazzano Journal: Am J Clin Nutr Date: 2019-06-01 Impact factor: 7.045
Authors: John E Morley; John C Morris; Marla Berg-Weger; Soo Borson; Brian D Carpenter; Natalia Del Campo; Bruno Dubois; Keith Fargo; L Jaime Fitten; Joseph H Flaherty; Mary Ganguli; George T Grossberg; Theodore K Malmstrom; Ronald D Petersen; Carroll Rodriguez; Andrew J Saykin; Philip Scheltens; Eric G Tangalos; Joe Verghese; Gordon Wilcock; Bengt Winblad; Jean Woo; Bruno Vellas Journal: J Am Med Dir Assoc Date: 2015-09-01 Impact factor: 4.669
Authors: Andrea M McGrattan; Claire T McEvoy; Bernadette McGuinness; Michelle C McKinley; Jayne V Woodside Journal: Br J Nutr Date: 2018-11-09 Impact factor: 3.718
Authors: C Galbete; E Toledo; J B Toledo; M Bes-Rastrollo; P Buil-Cosiales; A Marti; F Guillén-Grima; M A Martínez-González Journal: J Nutr Health Aging Date: 2015-03 Impact factor: 4.075
Authors: Agnes A M Berendsen; Jae H Kang; Ondine van de Rest; Nicole Jankovic; Ellen Kampman; Jessica C Kiefte-de Jong; Oscar H Franco; M Arfan Ikram; Hynek Pikhart; Lena Maria Nilsson; Hermann Brenner; Paolo Boffetta; Snorri Bjorn Rafnsson; Deborah Gustafson; Andreas Kyrozis; Antonia Trichopoulou; Edith J M Feskens; Francine Grodstein; Lisette C P G M de Groot Journal: Dement Geriatr Cogn Disord Date: 2017-03-22 Impact factor: 2.959